Rallybio Corp (RLYB) Operating Income (Loss) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rallybio Corp quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Rallybio Corp Operating Income (Loss) for the quarter ending March 31, 2024 was -$19.8 M, a 7.69% decline year-over-year.
  • Rallybio Corp Operating Income (Loss) for the twelve months ending March 31, 2024 was -$80.3 M, a 11.7% decline year-over-year.
  • Rallybio Corp annual Operating Income (Loss) for 2023 was -$78.9 M, a 16.3% decline from 2022.
  • Rallybio Corp annual Operating Income (Loss) for 2022 was -$67.9 M, a 48.7% decline from 2021.
  • Rallybio Corp annual Operating Income (Loss) for 2021 was -$45.6 M, a 80.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$80.3 M -$19.8 M -$1.41 M -7.69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$78.9 M -$21.1 M -$4.02 M -23.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$74.9 M -$19.4 M -$503 K -2.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$74.4 M -$20.1 M -$2.47 M -14% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$71.9 M -$18.4 M -$4.06 M -28.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$67.9 M -$17.1 M -$4.78 M -38.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$63.1 M -$18.9 M -$8.88 M -89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$54.2 M -$17.6 M -$7.09 M -67.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$47.1 M -$14.3 M -$1.49 M -11.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$45.6 M -$12.3 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$9.98 M -$3.27 M -48.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$10.5 M -$5.87 M -126% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$12.8 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$6.71 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.66 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.